Colorectal cancer liver metastases - understanding the differences in the management of synchronous and metachronous disease

Annals of the Academy of Medicine Singapore

Volumn 39, Issue 9, 2010, Pages 719-733

  Tan, Ek Khoon ^a   Ooi, London Lucien P J ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Colorectal neoplasms; Liver neoplasms; Metachronous cancer; Neoplasm metastasis; Synchronous cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLOOXYGENASE 2; FLOXURIDINE; FLUOROURACIL; FOLINIC ACID; GELATINASE A; MITOMYCIN; MUCIN 1; MUCIN 2; PROTEIN P53; SOMATOMEDIN B; TRANSFORMING GROWTH FACTOR ALPHA;

AGE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHRONICITY; CLINICAL TRIAL; COLORECTAL CANCER; COLORECTAL SURGERY; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; LENGTH OF STAY; LIVER METASTASIS; LIVER RESECTION; MICROWAVE THERAPY; MORBIDITY; RADIOFREQUENCY ABLATION; REVIEW; SURVIVAL RATE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TUMOR VASCULARIZATION; TUMOR VOLUME;

EID: 78149233414     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Review

References (91)

1. Seow AWPK, Chia KS, Shi LM, Lee HP, Shanmugaratnam K. Trends In Cancer Incidence in Singapore 1968 - 2002. Singapore: Singapore Cancer Registry; 2004. Report No.: 6.
2. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
3. Dukes CE. The classification of cancer of the rectum. J Patho l 1932;35:323-32.
4. Dukes CE. The Surgical Pathology of Rectal Cancer. J Clin Pathol 1949;2:95-8.
5. Greene FL. AJCC Cancer Staging Manual. 6th ed. Chicago, Illinois: Springer, 2002.
6. O'Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 2004;96:1420-5.
7. Wagner JS, Adson MA, Van Heerden JA, Adson MH, Ilstrup DM. The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg 1984;199:502-8.
8. Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J. Factors influencing the natural history of colorectal liver metastases. Lancet 1994;343:1405-10.
9. Bengtsson G, Carlsson G, Hafstrom L, Jonsson PE. Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg 1981;141:586-9.
10. Mancini R, Ettorre G, Vennarecci G, Sperduti I, Garufi C, Esposito A, et al. Personal experience on treatment of colorectal liver metastases: a multidisciplinary approach. J Exp Clin Cancer Res 2003;22(4 Suppl):213-7.
11. Leporrier J, Maurel J, Chiche L, Bara S, Segol P, Launoy G. A populationbased study of the incidence, management and prognosis of hepatic metastases from colorectal cancer. Br J Surg 2006;93:465-74.
12. Rougier P, Milan C, Lazorthes F, Fourtanier G, Partensky C, Baumel H, et al. Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer. Fondation Francaise de Cancerologie Digestive. Br J Surg 1995;82:1397-400.
13. Luna-Perez P, Rodriguez-Coria DF, Arroyo B, Gonzalez-Macouzet J. The natural history of liver metastases from colorectal cancer. Arch Med Res 1998;29:319-24.
14. Palmer M, Petrelli NJ, Herrera L. No treatment option for liver metastases from colorectal adenocarcinoma. Dis Colon Rectum 1989;32:698-701.
15. Wanebo HJ, Semoglou C, Attiyeh F, Stearns MJ, Jr. Surgical management of patients with primary operable colorectal cancer and synchronous liver metastases. Am J Surg 1978;135:81-5.
16. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg 1995;19:59-71.
17. Ballantyne GH, Quin J. Surgical treatment of liver metastases in patients with colorectal cancer. Cancer 1993;71(12 Suppl):4252-66.
18. Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg 2006;244:254-9.
19. Silen W. Hepatic resection for metastases from colorectal carcinoma is of dubious value. Arch Surg 1989;124:1021-2.
20. Adam R, Avisar E, Ariche A, Giachetti S, Azoulay D, Castaing D, et al. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol 2001;8:347-53.
21. Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 2004;240:644-57; discussion 657-8.
22. Ekberg H, Tranberg KG, Andersson R, Lundstedt C, Hagerstrand I, Ranstam J, et al. Determinants of survival in liver resection for colorectal secondaries. Br J Surg 1986;73:727-31.
23. Martin R, Paty P, Fong Y, Grace A, Cohen A, DeMatteo R, et al. Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg 2003;197:233- 41; discussion 241-2.
24. Lambert LA, Colacchio TA, Barth RJ, Jr. Interval hepatic resection of colorectal metastases improves patient selection. Arch Surg 2000;135:473- 9; discussion 479-80.
25. Ueno H, Mochizuki H, Hatsuse K, Hase K, Yamamoto T. Indicators for treatment strategies of colorectal liver metastases. Ann Surg 2000;231:59-66.
26. Compton CC. Key issues in reporting common cancer specimens: problems in pathologic staging of colon cancer. Arch Pathol Lab Med 2006;130:318-24.
27. Taniai N, Yoshida H, Mamada Y, Matsumoto S, Mizuguchi Y, Suzuki H, et al. Outcome of surgical treatment of synchronous liver metastases from colorectal cancer. J Nippon Med Sch 2006;73:82-8.
28. Alwan M, Stubbs R. Local recurrence in patients with synchronous or metachronous colorectal liver metastases-is there a difference? N Z Med J 2005;118:U1631.
29. Bockhorn M, Frilling A, Fruhauf NR, Neuhaus J, Molmenti E, Trarbach T, et al. Survival of patients with synchronous and metachronous colorectal liver metastases-is there a difference? J Gastrointest Surg 2008;12:1399-405.
30. Tsai MS, Su YH, Ho MC, Liang JT, Chen TP, Lai HS, et al. Clinicopathological features and prognosis in resectable sync hronous and metachronous colorectal liver metastasis. Ann Surg Oncol 2007;14:786-94.
31. Minagawa M, Yamamoto J, Kosuge T, Matsuyama Y, Miyagawa S, Makuuchi M. Simplified staging system for predicting the prognosis of patients with resectable liver metastasis: development and validation. Arch Surg 2007;142:269-76; discussion 277.
32. Fujita S, Akasu T, Moriya Y. Resection of synchronous liver metastases from colorectal cancer. Jpn J Clin Oncol 2000;30:7-11.
33. Kawamoto K, Onodera H, Kan S, Kondo S, Imamura M. Possible paracrine mechanism of insulin-like growth factor-2 in the development of liver metastases from colorectal carcinoma. Cancer 1999;85:18-25.
34. Li SR, Ng CF, Banerjea A, Ahmed S, Hands R, Powar M, et al. Differential expression patterns of the insulin-like growth factor 2 gene in human colorectal cancer. Tumour Biol 2004;25:62-8.
35. Wagenaar-Miller RA, Gorden L, Matrisian LM. Matrix metalloproteinases in colorectal cancer: is it worth talking about? Cancer Metastasis Rev 2004;23:119-35.
36. Oshima T, Kunisaki C, Yoshihara K, Yamada R, Yamamoto N, Sato T, et al. Clinicopathological significance of the gene expression of matrix metalloproteinases and reversion-inducing cysteine-rich protein with Kazal motifs in patients with colorectal cancer: MMP-2 gene expression is a useful predictor of liver metastasis from colorectal cancer. Oncol Rep 2008;19:1285-91.
37. Barozzi C, Ravaioli M, D'Errico A, Grazi GL, Poggioli G, Cavrini G, et al. Relevance of biologic markers in colorectal carcinoma: a comparative study of a broad panel. Cancer 2002;94:647-57.
38. De Jong KP, Stellema R, Karrenbeld A, Koudstaal J, Gouw AS, Sluiter WJ, et al. Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors. Hepatology 1998;28:971-9.
39. Matsuda K, Masaki T, Watanabe T, Kitayama J, Nagawa H, Muto T, et al. Clinical significance of MUC1 and MUC2 mucin and p53 protein expression in colorectal carcinoma. Jpn J Clin Oncol 2000;30:89-94.
40. Suzuki H, Shoda J, Kawamoto T, Shinozaki E, Miyahara N, Hotta S, et al. Expression of MUC1 recognized by monoclonal antibody MY.1E12 is a useful biomarker for tumor aggressiveness of advanced colon carcinoma. Clin Exp Metastasis 2004;21:321-9.
41. Okano K, Shimoda T, Matsumura Y. Clinicopathologic and immunohistochemical study of early colorectal cancer with liver metastases. J Gastroenterol 1999;34:334-40.
42. Yonezawa S, Sato E. Expression of mucin antigens in human cancers and its relationship with malignancy potential. Pathol Int 1997;47:813-30.
43. Thomas GV, Szigeti K, Murphy M, Draetta G, Pagano M, Loda M. Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases. Am J Pathol 1998;153:681-7.
44. Pantaleo MA, Astolfi A, Nannini M, Paterini P, Piazzi G, Ercolani G, et al. Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choice. Br J Cancer 2008;99:1729-34.
45. Ouchi K, Sugawara T, Ono H, Fujiya T, Kamiyama Y, Kakugawa Y, et al. Histologic features and clinical significance of venous invasion in colorectal carcinoma with hepatic metastasis. Cancer 1996;78:2313-7.
46. Sumiyoshi Y, Yamashita Y, Maekawa T, Sakai N, Shirakusa T, Kikuchi M. Expression of CD44, vascular endothelial growth factor, and proliferating cell nuclear antigen in severe venous invasional colorectal cancer and its relationship to liver metastasis. Surg Today 2000;30:323-7.
47. Mooteri S, Rubin D, Leurgans S, Jakate S, Drab E, Saclarides T. Tumor angiogenesis in primary and metastatic colorectal cancers. Dis Colon Rectum 1996;39:1073-80.
48. Suzuki A, Masuda A, Nagata H, Kameoka S, Kikawada Y, Yamakawa M, et al. Mature dendritic cells make clusters with T cells in the invasive margin of colorectal carcinoma. J Pathol 2002;196:37-43.
49. Miyagawa S, Soeda J, Takagi S, Miwa S, Ichikawa E, Noike T. Prognostic significance of mature dendritic cells and factors associated with their accumulation in metastatic liver tumors from colorectal cancer. Hum Pathol 2004;35:1392-6.
50. Coppa GF, Eng K, Ranson JH, Gouge TH, Localio SA. Hepatic resection for metastatic colon and rectal cancer. An evaluation of preoperative and postoperative factors. Ann Surg 1985;202:203-8.
51. Nordlinger B, Quilichini MA, Parc R, Hannoun L, Delva E, Huguet C. Hepatic resection for colorectal liver metastases. Influence on survival of preoperative factors and surgery for recurrences in 80 patients. Ann Surg 1987;205:256-63.
52. Sugihara K, Hojo K, Moriya Y, Yamasaki S, Kosuge T, Takayama T. Pattern of recurrence after hepatic resection for colorectal metastases. Br J Surg 1993;80:1032-5.
53. Jatzko GR, Lisborg PH, Stettner HM, Klimpfinger MH. Hepatic resection for metastases from colorectal carcinoma-a survival analysis. Eur J Cancer 1995;31A:41-6.
54. Taylor M, Forster J, Langer B, Taylor BR, Greig PD, Mahut C. A study of prognostic factors for hepatic resection for colorectal metastases. Am J Surg 1997;173:467-71.
55. Rees M, Plant G, Bygrave S. Late results justify resection for multiple hepatic metastases from colorectal cancer. Br J Surg 1997;84:1136-40.
56. Irie T, Itai Y, Hatsuse K, Mochizuki H. Does resection of small liver metastases from colorectal cancer improve survival of patients? Br J Radiol 1999;72:246-9.
57. Weber JC, Nakano H, Bachellier P, Oussoultzoglou E, Inoue K, Shimura H, et al. Is a proliferation index of cancer cells a reliable prognostic factor after hepatectomy in patients with colorectal liver metastases? Am J Surg 2001;182:81-8.
58. Bramhall SR, Gur U, Coldham C, Gunson BK, Mayer AD, McMaster P, et al. Liver resection for colorectal metastases. Ann R Coll Surg Engl 2003;85:334-9.
59. Shah SA, Haddad R, Al-Sukhni W, Kim RD, Greig PD, Grant DR, et al. Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma. J Am Coll Surg 2006;202:468-75.
60. Wang X, Hershman DL, Abrams JA, Feingold D, Grann VR, Jacobson JS, et al. Predictors of survival after hepatic resection among patients with colorectal liver metastasis. Br J Cancer 2007;97:1606-12.
61. Nuzzo G, Giuliante F, Ardito F, Vellone M, Giovannini I, Federico B, et al. Influence of surgical margin on type of recurrence after liver resection for colorectal metastases: a single-center experience. Surgery 2008;143:384-93.
62. Hamady ZZ, Malik HZ, Alwan N, Wyatt JI, Prasad KR, Toogood GJ, et al. Surgeon's awareness of the synchronous liver metastases during colorectal cancer resection may affect outcome. Eur J Surg Oncol 2008;34:180-4.
63. Liu CL, Fan ST, Lo CM, Law WL, Ng IO, Wong J. Hepatic resection for colorectal liver metastases: prospective study. Hong Kong Med J 2002;8:329-33.
64. de Haas RJ, Wicherts DA, Flores E, Azoulay D, Castaing D, Adam R. R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery? Ann Surg 2008;248:626-37.
65. Bismuth H, Adam R, Levi F, Farabos C, Waechter F, Castaing D, et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996;224:509-20; discussion 520-2.
66. Pozzo C, Basso M, Cassano A, Quirino M, Schinzari G, Trigila N, et al. Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients. Ann Oncol 2004;15:933-9.
67. Poston GJ, Adam R, Alberts S, Curley S, Figueras J, Haller D, et al. OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer. J Clin Oncol 2005;23:7125-34.
68. Lyass S, Zamir G, Matot I, Goitein D, Eid A, Jurim O. Combined colon and hepatic resection for synchronous colorectal liver metastases. J Surg Oncol 2001;78:17-21.
69. Peeters CF, Westphal JR, de Waal RM, Ruiter DJ, Wobbes T, Ruers TJ. Vascular density in colorectal liver metastases increases after removal of the primary tumor in human cancer patients. Int J Cancer 2004;112:554-9.
70. Peeters CF, de Waal RM, Wobbes T, Westphal JR, Ruers TJ. Outgrowth of human liver metastases after resection of the primary colorectal tumor: a shift in the balance between apoptosis and proliferation. Int J Cancer 2006;119:1249-53.
71. Minagawa M, Yamamoto J, Miwa S, Sakamoto Y, Kokudo N, Kosuge T, et al. Selection criteria for simultaneous resection in patients with synchronous liver metastasis. Arch Surg 2006;141:1006-12; discussion 1013.
72. Finlay IG, Meek D, Brunton F, McArdle CS. Growth rate of hepatic metastases in colorectal carcinoma. Br J Surg 1988;75:641-4.
73. Shimizu Y, Yasui K, Sano T, Hirai T, Kanemitsu Y, Komori K, et al. Validity of observation interval for synchronous hepatic metastases of colorectal cancer: changes in hepatic and extrahepatic metastatic foci. Langenbecks Arch Surg 2008;393:181-4.
74. Yoshidome H, Kimura F, Shimizu H, Ohtsuka M, Kato A, Yoshitomi H, et al. Interval period tumor progression: does delayed hepatectomy detect occult metastases in synchronous colorectal liver metastases? J Gastrointest Surg 2008;12:1391-8.
75. Lygidakis NJ, Singh G, Bardaxoglou E, Dedemadi G, Sgourakis G, Nestoridis J, et al. Two-stage liver surgery for advanced liver metastasis synchronous with colorectal tumor. Hepatogastroenterology 2004;51:413-8.
76. Allen PJ, Kemeny N, Jarnagin W, DeMatteo R, Blumgart L, Fong Y. Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. J Gastrointest Surg 2003;7:109-15; discussion 116-7.
77. Scheele J, Rudroff C, Altendorf-Hofmann A. Resection of colorectal liver metastases revisited. J Gastrointest Surg 1997;1:408-22.
78. Vogt P, Raab R, Ringe B, Pichlmayr R. Resection of synchronous liver metastases from colorectal cancer. World J Surg 1991;15:62-7.
79. Weber JC, Bachellier P, Oussoultzoglou E, Jaeck D. Simultaneous resection of colorectal primary tumour and synchronous liver metastases. Br J Surg 2003;90:956-62.
80. Chua HK, Sondenaa K, Tsiotos GG, Larson DR, Wolff BG, Nagorney DM. Concurrent vs. staged colectomy and hepatectomy for primary colorectal cancer with synchronous hepatic metastases. Dis Colon Rectum 2004;47:1310-6.
81. Tanaka K, Shimada H, Matsuo K, Nagano Y, Endo I, Sekido H, et al. Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases. Surgery 2004;136:650-9.
82. Capussotti L, Vigano L, Ferrero A, Lo Tesoriere R, Ribero D, Polastri R. Timing of resection of liver metastases synchronous to colorectal tumor: proposal of prognosis-based decisional model. Ann Surg Oncol 2007;14:1143-50.
83. Reddy SK, Pawlik TM, Zorzi D, Gleisner AL, Ribero D, Assumpcao L, et al. Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis. Ann Surg Oncol 2007;14:3481-91.
84. Thelen A, Jonas S, Benckert C, Spinelli A, Lopez-Hanninen E, Rudolph B, et al. Simultaneous versus staged liver resection of synchronous liver metastases from colorectal cancer. Int J Colorectal Dis 2007;22:1269-76.
85. Yan TD, Chu F, Black D, King DW, Morris DL. Synchronous resection of colorectal primary cancer and liver metastases. World J Surg 2007;31:1496-501.
86. Turrini O, Viret F, Guiramand J, Lelong B, Bege T, Delpero JR. Strategies for the treatment of synchronous liver metastasis. Eur J Surg Oncol 2007;33:735-40.
87. Vassiliou I, Arkadopoulos N, Theodosopoulos T, Fragulidis G, Marinis A, Kondi-Paphiti A, et al. Surgical approaches of resectable synchronous colorectal liver metastases: timing considerations. World J Gastroenterol 2007;13:1431-4.
88. Strasberg SM. Terminology of liver anatomy and liver resections: coming to grips with hepatic Babel. J Am Coll Surg 1997;184:413-34.
89. Jovine E, Biolchini F, Talarico F, Lerro FM, Mastrangelo L, Selleri S, et al. Major hepatectomy in patients with synchronous colorectal liver metastases: whether or not a contraindication to simultaneous colorectal and liver resection? Colorectal Dis 2007;9:245-52.
90. Capussotti L, Ferrero A, Vigano L, Ribero D, Lo Tesoriere R, Polastri R. Major liver resections synchronous with colorectal surgery. Ann Surg Oncol 2007;14:195-201.
91. Kim SH, Lim SB, Ha YH, Han SS, Park SJ, Choi HS, et al. Laparoscopic- Assisted Combined Colon and Liver Resection for Primary Colorectal Cancer with Synchronous Liver Metastases: Initial Experience. World J Surg 2008;32:2701-6.